• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Deal with GE boosts Fischer results

Article

A $6.2 million windfall from the sale of its Tilt-C technology to GE Medical Systems helped Fischer Imaging of Denver land solidly in the black for its first quarter (end-April). The company also reported a 3.6% increase in product sales for the quarter

A $6.2 million windfall from the sale of its Tilt-C technology to GE Medical Systems helped Fischer Imaging of Denver land solidly in the black for its first quarter (end-April). The company also reported a 3.6% increase in product sales for the quarter on higher service revenue and increased mammography shipments.

Fischer posted revenues of $20.4 million, compared with sales of $13.7 million in the first quarter of 1998. Excluding the GE payment, Fischer would have posted sales of $14.2 million. Fischer in April agreed to sell manufacturing rights to Tilt-C to Milwaukee-based GE (SCAN 4/14/99).

On the profit side, Fischer recorded net income of $3.4 million, compared with a net loss of $1.1 million in the same period a year ago. The company posted an operating loss of $1.6 million for the quarter, due in large part to costs associated with the move of its manufacturing operations from Addison, IL, to Denver.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.